dr. ahmed on the impact of neratinib on cns metastases in her2 breast cancer
Published 3 years ago • 145 plays • Length 1:09Download video MP4
Download video MP3
Similar videos
-
1:20
dr. ahmed on remaining questions with tucatinib in breast cancer brain metastases
-
1:28
dr. dawar on challenges with neratinib in metastatic her2 breast cancer
-
5:21
study of neratinib for patients with her2-positive breast cancer with brain metastases
-
1:39
dr. anders discusses the use of neratinib/capecitabine for her2-positive brain metastases
-
3:15
neratinib for metastatic breast cancer
-
1:19
dr. pegram discusses the use of neratinib in her2 breast cancer
-
9:35
neratinib in her2 breast cancer
-
1:24
dr. ahmed on the role of multidisciplinary care in breast cancer brain metastases
-
0:50
dr. white on cns metastases in her2 breast cancer
-
6:41
the emerging role of neratinib in her2 mbc
-
1:14
dr. lin on cns-specific outcomes with neratinib in her2 breast cancer
-
2:18
use of neratinib in her2-positive breast cancer
-
1:14
dr. hamilton on how neratinib targets her2 breast cancer
-
1:30
dr. czerniecki on treatment options for patients with her2 brain metastases
-
1:36
dr. mortimer on brain metastases in her2 breast cancer
-
5:02
brain metastases in her2-positive breast cancer
-
0:48
dr. czerniecki on the benefit of tucatinib in her2 breast cancer and brain metastases
-
1:09
dr. dang on neratinib in patients with her2 breast cancer
-
4:09
her2 breast cancer: neratinib patient selection